ABVC BIOPHARMA, INC.: $3 million Raised, SEC Form D Filings
ABVC BIOPHARMA, INC., a listed company (ABVC) in Fremont, California, reported $3 million sold in a Form D filed 10 November 2026. Its Form D notices are private placements by a public company, not startup rounds.
Company · Biotechnology · CA · SEC CIK 1173313 · Company page
Form D notices
A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.
| Filed | Type | Offering | Sold | Industry | |
|---|---|---|---|---|---|
| 10 Nov 2026 | New notice | $3 million | $3 million | Biotechnology | Form D |
Questions and answers
- How much has ABVC BIOPHARMA, INC. raised?
- ABVC BIOPHARMA, INC. reported $3 million sold in its largest Form D notice on file; its latest notice was filed on 10 November 2026. Form D amounts are what the issuer reported to the SEC.
- Is ABVC BIOPHARMA, INC. a startup?
- No. ABVC BIOPHARMA, INC. is a listed company (ABVC); a listed company files a Form D when it sells shares directly to chosen investors.
- What is ABVC BIOPHARMA, INC.?
- ABVC BIOPHARMA, INC. is a company in biotechnology, based in Fremont, California, according to its SEC Form D filings.
- How many Form D notices has ABVC BIOPHARMA, INC. filed?
- 1 notice between 10 November 2026 and 10 November 2026 in Tamarly's record, which starts on 1 October 2025.
Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "ABVC BIOPHARMA, INC.: SEC Form D filings", https://app.tamarly.ai/raisers/1173313, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.